Basics |
Company: |
Genprex, Inc. |
IPO Date: |
March 29, 2018 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$4.42M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.12 | 4.92%
|
Avg Daily Range (30 D): |
$0.03 | 4.13%
|
Avg Daily Range (90 D): |
$0.09 | 8.12%
|
Institutional Daily Volume |
Avg Daily Volume: |
.32M |
Avg Daily Volume (30 D): |
.3M |
Avg Daily Volume (90 D): |
5.35M |
Trade Size |
Avg Trade Size (Sh.): |
89 |
Avg Trade Size (Sh.) (30 D): |
443 |
Avg Trade Size (Sh.) (90 D): |
316 |
Institutional Trades |
Total Inst.Trades: |
30 |
Avg Inst. Trade: |
$1.54M |
Avg Inst. Trade (30 D): |
$1.18M |
Avg Inst. Trade (90 D): |
$1.18M |
Avg Inst. Trade Volume: |
.02M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.5M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
23.79K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-11.61
|
$-1.23
|
$-3
|
Diluted EPS
|
|
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -22.71M
|
$ -4.32M
|
$ -6.5M
|
Operating Income / Loss
|
$ -22.83M
|
$ -4.32M
|
$ -6.52M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -10.22M
|
$ -.97M
|
$ -5.76M
|
PE Ratio
|
|
|
|
Splits |
Feb 02, 2024:
40:1
|
|